Christiana Dellorusso

Christiana DelloRusso joined LRVHealth as a Partner in 2021 with 20+ years of experience in technical product, business and funding strategy of early-to-mid-stage for-profit and non-profit ventures. Her experience as an “insider” strategic healthcare investor includes her role as one of the three initial Partners to launch Providence Ventures, the strategic venture capital arm of the Providence health system, in 2014. There Christiana led the firm’s investments in Omada Health, Lyra Health, and N-of-One (acquired by Qiagen). Before Providence Ventures, Christiana held roles as VP of Commercialization at Life Science Washington and Managing Director of WINGS, a medical technology angel investor network. Previous experience also includes consulting at venture-funded startup companies. Christiana earned her Ph.D. in Physiology from the University of Michigan, and completed post-doctoral studies at the University of Washington and Children’s Hospital Boston/Harvard Medical School.